Logo image of HELE

HELEN OF TROY LTD (HELE) Stock Fundamental Analysis

NASDAQ:HELE - Nasdaq - BMG4388N1065 - Common Stock - Currency: USD

58.795  +0.63 (+1.07%)

After market: 58.795 0 (0%)

Fundamental Rating

4

HELE gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 67 industry peers in the Household Durables industry. While HELE is still in line with the averages on profitability rating, there are concerns on its financial health. HELE has a valuation in line with the averages, but on the other hand it scores bad on growth.


Dividend Valuation Growth Profitability Health

5

1. Profitability

1.1 Basic Checks

HELE had positive earnings in the past year.
In the past year HELE had a positive cash flow from operations.
In the past 5 years HELE has always been profitable.
Each year in the past 5 years HELE had a positive operating cash flow.
HELE Yearly Net Income VS EBIT VS OCF VS FCFHELE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M

1.2 Ratios

HELE has a Return On Assets (3.89%) which is comparable to the rest of the industry.
With a Return On Equity value of 7.10%, HELE perfoms like the industry average, outperforming 43.08% of the companies in the same industry.
The Return On Invested Capital of HELE (6.01%) is comparable to the rest of the industry.
Industry RankSector Rank
ROA 3.89%
ROE 7.1%
ROIC 6.01%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
HELE Yearly ROA, ROE, ROICHELE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15 20

1.3 Margins

Looking at the Profit Margin, with a value of 6.05%, HELE is in line with its industry, outperforming 53.85% of the companies in the same industry.
In the last couple of years the Profit Margin of HELE has declined.
HELE has a Operating Margin (9.40%) which is in line with its industry peers.
HELE's Operating Margin has been stable in the last couple of years.
HELE's Gross Margin of 48.04% is amongst the best of the industry. HELE outperforms 89.23% of its industry peers.
In the last couple of years the Gross Margin of HELE has grown nicely.
Industry RankSector Rank
OM 9.4%
PM (TTM) 6.05%
GM 48.04%
OM growth 3Y-3.97%
OM growth 5Y-1.08%
PM growth 3Y-11.42%
PM growth 5Y-4.83%
GM growth 3Y2.31%
GM growth 5Y2.91%
HELE Yearly Profit, Operating, Gross MarginsHELE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30 40

3

2. Health

2.1 Basic Checks

HELE has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
There is no outstanding debt for HELE. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
HELE Yearly Shares OutstandingHELE Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 5M 10M 15M 20M 25M
HELE Yearly Total Debt VS Total AssetsHELE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 500M 1B 1.5B 2B 2.5B

2.2 Solvency

An Altman-Z score of 2.22 indicates that HELE is not a great score, but indicates only limited risk for bankruptcy at the moment.
HELE has a Altman-Z score of 2.22. This is in the lower half of the industry: HELE underperforms 66.15% of its industry peers.
HELE has a debt to FCF ratio of 5.98. This is a neutral value as HELE would need 5.98 years to pay back of all of its debts.
HELE has a Debt to FCF ratio (5.98) which is in line with its industry peers.
HELE has a Debt/Equity ratio of 0.45. This is a healthy value indicating a solid balance between debt and equity.
Looking at the Debt to Equity ratio, with a value of 0.45, HELE is doing worse than 63.08% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.45
Debt/FCF 5.98
Altman-Z 2.22
ROIC/WACC0.59
WACC10.2%
HELE Yearly LT Debt VS Equity VS FCFHELE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B

2.3 Liquidity

HELE has a Current Ratio of 1.92. This is a normal value and indicates that HELE is financially healthy and should not expect problems in meeting its short term obligations.
HELE has a Current ratio of 1.92. This is in the lower half of the industry: HELE underperforms 64.62% of its industry peers.
A Quick Ratio of 1.05 indicates that HELE should not have too much problems paying its short term obligations.
HELE has a Quick ratio (1.05) which is in line with its industry peers.
Industry RankSector Rank
Current Ratio 1.92
Quick Ratio 1.05
HELE Yearly Current Assets VS Current LiabilitesHELE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 200M 400M 600M 800M 1B

2

3. Growth

3.1 Past

The earnings per share for HELE have decreased strongly by -13.68% in the last year.
Measured over the past 5 years, HELE shows a small growth in Earnings Per Share. The EPS has been growing by 2.02% on average per year.
Looking at the last year, HELE shows a decrease in Revenue. The Revenue has decreased by -4.48% in the last year.
HELE shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 5.09% yearly.
EPS 1Y (TTM)-13.68%
EPS 3Y-8.46%
EPS 5Y2.02%
EPS Q2Q%-4.3%
Revenue 1Y (TTM)-4.48%
Revenue growth 3Y-1.51%
Revenue growth 5Y5.09%
Sales Q2Q%-3.44%

3.2 Future

HELE is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 0.31% yearly.
HELE is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 1.45% yearly.
EPS Next Y-17.19%
EPS Next 2Y-4.65%
EPS Next 3Y0.31%
EPS Next 5YN/A
Revenue Next Year-4.33%
Revenue Next 2Y0.81%
Revenue Next 3Y1.45%
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
HELE Yearly Revenue VS EstimatesHELE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 500M 1B 1.5B 2B
HELE Yearly EPS VS EstimatesHELE Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2 4 6 8 10

6

4. Valuation

4.1 Price/Earnings Ratio

HELE is valuated reasonably with a Price/Earnings ratio of 8.03.
Compared to the rest of the industry, the Price/Earnings ratio of HELE indicates a somewhat cheap valuation: HELE is cheaper than 76.92% of the companies listed in the same industry.
HELE is valuated cheaply when we compare the Price/Earnings ratio to 29.63, which is the current average of the S&P500 Index.
The Price/Forward Earnings ratio is 7.25, which indicates a rather cheap valuation of HELE.
Compared to the rest of the industry, the Price/Forward Earnings ratio of HELE indicates a rather cheap valuation: HELE is cheaper than 83.08% of the companies listed in the same industry.
When comparing the Price/Forward Earnings ratio of HELE to the average of the S&P500 Index (22.68), we can say HELE is valued rather cheaply.
Industry RankSector Rank
PE 8.03
Fwd PE 7.25
HELE Price Earnings VS Forward Price EarningsHELE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, HELE is valued a bit cheaper than 64.62% of the companies in the same industry.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of HELE indicates a rather cheap valuation: HELE is cheaper than 87.69% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 10.95
EV/EBITDA 8.61
HELE Per share dataHELE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 20 40 60 80

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)3.97
EPS Next 2Y-4.65%
EPS Next 3Y0.31%

0

5. Dividend

5.1 Amount

No dividends for HELE!.
Industry RankSector Rank
Dividend Yield N/A

HELEN OF TROY LTD

NASDAQ:HELE (2/21/2025, 8:25:21 PM)

After market: 58.795 0 (0%)

58.795

+0.63 (+1.07%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Durables & Apparel
GICS IndustryHousehold Durables
Earnings (Last)01-08 2025-01-08/bmo
Earnings (Next)N/A N/A
Inst Owners107.19%
Inst Owner Change-1.13%
Ins Owners1.22%
Ins Owner Change0.33%
Market Cap1.34B
Analysts75
Price Target87.47 (48.77%)
Short Float %9.48%
Short Ratio5.23
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)7.37%
Min EPS beat(2)1.33%
Max EPS beat(2)13.41%
EPS beat(4)3
Avg EPS beat(4)-4.95%
Min EPS beat(4)-39.07%
Max EPS beat(4)13.41%
EPS beat(8)6
Avg EPS beat(8)1.01%
EPS beat(12)10
Avg EPS beat(12)3.66%
EPS beat(16)13
Avg EPS beat(16)6.84%
Revenue beat(2)1
Avg Revenue beat(2)-0.47%
Min Revenue beat(2)-2.4%
Max Revenue beat(2)1.46%
Revenue beat(4)2
Avg Revenue beat(4)-2.18%
Min Revenue beat(4)-8.34%
Max Revenue beat(4)1.46%
Revenue beat(8)4
Avg Revenue beat(8)-0.8%
Revenue beat(12)6
Avg Revenue beat(12)1.25%
Revenue beat(16)10
Avg Revenue beat(16)3.37%
PT rev (1m)-3.11%
PT rev (3m)-1.15%
EPS NQ rev (1m)-0.41%
EPS NQ rev (3m)-6.16%
EPS NY rev (1m)0.72%
EPS NY rev (3m)0.89%
Revenue NQ rev (1m)0.14%
Revenue NQ rev (3m)-1.04%
Revenue NY rev (1m)-0.97%
Revenue NY rev (3m)0.05%
Valuation
Industry RankSector Rank
PE 8.03
Fwd PE 7.25
P/S 0.7
P/FCF 10.95
P/OCF 8.85
P/B 0.83
P/tB 35.99
EV/EBITDA 8.61
EPS(TTM)7.32
EY12.45%
EPS(NY)8.11
Fwd EY13.79%
FCF(TTM)5.37
FCFY9.13%
OCF(TTM)6.64
OCFY11.3%
SpS83.59
BVpS71.22
TBVpS1.63
PEG (NY)N/A
PEG (5Y)3.97
Profitability
Industry RankSector Rank
ROA 3.89%
ROE 7.1%
ROCE 7.32%
ROIC 6.01%
ROICexc 6.11%
ROICexgc 17.92%
OM 9.4%
PM (TTM) 6.05%
GM 48.04%
FCFM 6.42%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y-3.97%
OM growth 5Y-1.08%
PM growth 3Y-11.42%
PM growth 5Y-4.83%
GM growth 3Y2.31%
GM growth 5Y2.91%
F-Score7
Asset Turnover0.64
Health
Industry RankSector Rank
Debt/Equity 0.45
Debt/FCF 5.98
Debt/EBITDA 3.09
Cap/Depr 52.64%
Cap/Sales 1.52%
Interest Coverage 250
Cash Conversion 64.6%
Profit Quality 106.19%
Current Ratio 1.92
Quick Ratio 1.05
Altman-Z 2.22
F-Score7
WACC10.2%
ROIC/WACC0.59
Cap/Depr(3y)226.77%
Cap/Depr(5y)197.94%
Cap/Sales(3y)4.59%
Cap/Sales(5y)3.9%
Profit Quality(3y)70.37%
Profit Quality(5y)92.48%
High Growth Momentum
Growth
EPS 1Y (TTM)-13.68%
EPS 3Y-8.46%
EPS 5Y2.02%
EPS Q2Q%-4.3%
EPS Next Y-17.19%
EPS Next 2Y-4.65%
EPS Next 3Y0.31%
EPS Next 5YN/A
Revenue 1Y (TTM)-4.48%
Revenue growth 3Y-1.51%
Revenue growth 5Y5.09%
Sales Q2Q%-3.44%
Revenue Next Year-4.33%
Revenue Next 2Y0.81%
Revenue Next 3Y1.45%
Revenue Next 5YN/A
EBIT growth 1Y-36.59%
EBIT growth 3Y-5.42%
EBIT growth 5Y3.96%
EBIT Next Year2.38%
EBIT Next 3Y4.45%
EBIT Next 5YN/A
FCF growth 1Y866.35%
FCF growth 3Y7.74%
FCF growth 5Y9.79%
OCF growth 1Y-22.29%
OCF growth 3Y-0.86%
OCF growth 5Y9.4%